Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 3Neuroblastoma 2Neoplasms 2Glioma 2Wilms Tumor 1Sarcoma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Nerve Tissue 1Melanoma 1Medulloblastoma 1Diffuse Intrinsic Pontine Glioma 1Brain Neoplasms 1

Interventions

Bevacizumab 3contrast agent BR1 2Oncolytic Virotherapy 2vorasidenib 1pembrolizumab 1keyhole-limpet hemocyanin 1interferon gamma-1b 1Vaccines 1Temozolomide 1Stem Cell Transplantation 1Microbubbles 1Interleukin-12 1Interferon-gamma 1Immunotherapy 1Biopsy 1Antibodies, Monoclonal 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Nerve Tissue × Vaccines × CNS × Clear all
NCT02745756 2017-08-30

A Combined Cell Therapy Approach to the Treatment of Neuroblastoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Withdrawn
CNS

Neoplasms, Neoplasms, Nerve Tissue, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡